Martin Rosenberg
Direktor/Vorstandsmitglied bei Medical College of Wisconsin Research Foundation
Profil
Martin Rosenberg is currently a Director at the Medical College of Wisconsin Research Foundation, Scarab Genomics LLC, International Biomedical Research Alliance, and a Professor at the University of Wisconsin.
He previously worked as an Independent Director at Cubist Pharmaceuticals LLC, Director-Emeritus at Nereus Pharmaceuticals, Inc., Director at Anacor Pharmaceuticals LLC, Senior Vice President-Anti Infectives at Smithkline Beecham Plc, Senior VP-Anti Infectives & Drug Discovery at GSK Plc, Chief Scientific Officer at Promega Corp., Advisor at VantagePoint Management, Inc., Section Chief at National Cancer Institute, and Senior Vice President-Anti Infectives at GlaxoSmithKline LLC.
He received his undergraduate degree from the University of Rochester and his doctorate from Purdue University.
Aktive Positionen von Martin Rosenberg
| Unternehmen | Position | Beginn |
|---|---|---|
| Medical College of Wisconsin Research Foundation | Direktor/Vorstandsmitglied | - |
Scarab Genomics LLC
 Scarab Genomics LLC BiotechnologyHealth Technology Scarab Genomics LLC specializes in providing the most robust bacterial fermentation host for general/routine recombinant protein expression and nucleic acid production. The private company is based in Madison, WI and was founded by Trevor M. Twose. The company's Clean Genome® technology reduces the mutation rate to almost zero, even under the most stressful conditions. Scarab Genomics offers Clean Genome® LowMut T7, which provides a T7 promoter in the genome for clients wishing to use this expression option rather than the recommended synthetic T5 promoter in the pSX2 vector. Scarab Genomics also offers an insertion sequence (IS) detection kit that tests for the presence of all known E. coli IS elements in any DNA sample of interest. | Direktor/Vorstandsmitglied | - |
| University of Wisconsin | Corporate Officer/Principal | - |
International Biomedical Research Alliance
 International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Martin Rosenberg
| Unternehmen | Position | Ende |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 27.03.2014 |
Nereus Pharmaceuticals, Inc.
 Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 13.08.2012 |
| GSK PLC | Corporate Officer/Principal | 01.01.2001 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Corporate Officer/Principal | 01.01.2000 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
Ausbildung von Martin Rosenberg
| Rochester Christian University | Undergraduate Degree |
| Purdue University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private Unternehmen | 11 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA. | Health Technology |
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Smithkline Beecham Plc develops and manufactures pharmaceutical products. The company markets pharmaceuticals for human and animal healthcare consumption, vaccines, over the counter medicines, health related consumer products, clinical laboratory testing services, disease management and pharmaceutical benefit management. It is headquartered in Brentford, UK. | Health Technology |
Promega Corp.
 Promega Corp. BiotechnologyHealth Technology Promega Corp. manufactures enzyme systems. Its products include cell biology, nucleic acid analysis, drug development, molecular diagnostics, and lab equipment and supplies. The company was founded by William Alderman Linton in 1978 and is headquartered in Madison, WI. | Health Technology |
VantagePoint Management, Inc.
 VantagePoint Management, Inc. Investment ManagersFinance VantagePoint Management, Inc. (VantagePoint) is a venture capital firm founded in 1996 by Alan Edward Salzman, James D. Marver. The firm is headquartered in Santa Barbara, California with additional office in Beijing, China. | Finance |
Nereus Pharmaceuticals, Inc.
Nereus Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Nereus Pharmaceuticals, Inc. is a drug discovery and development company pursuing untapped sources of chemical diversity through identifying drug candidates derived from marine microbes. Nereus' discovery portfolio also includes additional drug candidates for oncology, inflammation, and infectious diseases. The company was founded in 1998 and is headquartered in San Diego, CA. | Commercial Services |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
Anacor Pharmaceuticals LLC
 Anacor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Anacor Pharmaceuticals, Inc. develops medical solutions. The firm operates as a biopharmaceutical company, which focuses on discovering, developing, and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company was founded by Lucy Shapiro, Stephen J. Benkovic, and David P. Perry in 2000 and is headquartered in Palo Alto, CA. | Health Technology |
| Medical College of Wisconsin Research Foundation | |
Scarab Genomics LLC
Scarab Genomics LLC BiotechnologyHealth Technology Scarab Genomics LLC specializes in providing the most robust bacterial fermentation host for general/routine recombinant protein expression and nucleic acid production. The private company is based in Madison, WI and was founded by Trevor M. Twose. The company's Clean Genome® technology reduces the mutation rate to almost zero, even under the most stressful conditions. Scarab Genomics offers Clean Genome® LowMut T7, which provides a T7 promoter in the genome for clients wishing to use this expression option rather than the recommended synthetic T5 promoter in the pSX2 vector. Scarab Genomics also offers an insertion sequence (IS) detection kit that tests for the presence of all known E. coli IS elements in any DNA sample of interest. | Health Technology |
International Biomedical Research Alliance
International Biomedical Research Alliance Miscellaneous Commercial ServicesCommercial Services The International Biomedical Research Alliance supports the NIH Oxford-Cambridge Scholars Program and associated global Ph.D. and M.D./Ph.D. training programs based in the Intramural Research Program of the National Institutes of Health. The company was founded in 2005 and is headquartered in Bethesda, MD. | Commercial Services |
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
